Form 4: GE HealthCare Executive Adam Holton Reports Stock and Option Awards
SEC Form 4 Filing
Chief People Officer Adam Holton reports the acquisition of restricted stock and stock options in GE HealthCare Technologies Inc.
Summary
- Adam Holton, Chief People Officer of GE HealthCare Technologies Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the acquisition of 4,396 shares of restricted stock that vest in three tranches: 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027.
- Holton also acquired 8,499 shares of restricted stock that vest 50% on August 15, 2026, and 50% on August 15, 2027.
- Additionally, Holton was granted an employee stock option for 13,293 shares, exercisable in three tranches: 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027.
- The exercise price for the stock options is $85.30.
- Following these transactions, Holton directly owns 12,895 shares of GE HealthCare common stock and holds options for 13,293 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating executive compensation, which is neither overtly positive nor negative.
Positives
- The grant of restricted stock and stock options to a key executive like the Chief People Officer can be seen as a positive sign, aligning their interests with the long-term performance of the company.
- The vesting schedules encourage long-term commitment from the executive.
Future Outlook
The document does not contain specific forward-looking statements about the company's future performance, but the vesting schedules of the stock awards suggest a focus on long-term value creation.
Industry Context
Stock and option awards are a common practice in the healthcare industry to incentivize and retain key executives. The vesting schedules are typical for such awards.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock, are standard practice among publicly traded companies like GE HealthCare.
- Companies such as Siemens Healthineers and Philips also utilize similar compensation strategies to align executive interests with shareholder value.
- The vesting schedules outlined in the document are consistent with industry norms, typically spanning three to four years to encourage long-term commitment.
Stakeholder Impact
- The stock and option awards could have a minor positive impact on shareholder sentiment, as they align executive interests with the company's long-term success.
- Employees may view the awards as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Date of the reported transactions (stock and option awards). |
| 08/19/2024 | Date of the Form 4 filing. |
| 09/01/2025 | First vesting date for 33% of the first restricted stock award and 33% of the stock options. |
| 08/15/2026 | First vesting date for 50% of the second restricted stock award. |
| 09/01/2026 | Second vesting date for 33% of the first restricted stock award and 33% of the stock options. |
| 08/15/2027 | Second vesting date for 50% of the second restricted stock award. |
| 09/01/2027 | Final vesting date for 34% of the first restricted stock award and 34% of the stock options. |
| 08/15/2034 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.